2Amrett FC,Edworh S,Blook DA, et al. The American rheumatism association 1987 rivised criteria for the classification of rheumatoid arthritis [J].Arthritis Rheum,1988,31(3):315～324
3Gudbjornsson B,Hallgren R,Wide L, et al. Response of anemia in rh-eumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin [J].Ann Rheum Dis,1992,51(6):747～750
4Fitzsimons EJ,Sturrock RD.The chronic anaemia of rheumatoid arthrits:iron banking or blocking [J]?Lancet,2002,360(9347):1713～1714
5Nordstrom D,Lindroth Y,Marsal L, et al. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis [J].Rheumatol Int,1997,17(2):67～73
7Peeters HR,Jongen-Lavrencic M,Vreugdenhil G, et al. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease:a randomised palcebo controlled double blind 52 weeks clinical trial [J].Ann Rheum Dis,1996,55(10):739～744
8Kaltwasser JP,Kessler U,Gottschalk R, et al. Effect of recombinant human erythropoietin and intravenous iron on anermia and disease activity in rheumatoid arthritis [J].J Rheumatol,2001,28(11):2430～2436
3Iscove NN, Sieber F, Winterhalter KH-. Erythroid colony formation in eultures of mouse and human bone marrow: analysis of the requirement of erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol, 1974,83:309-320.
4Lellesjo H, Nordstrom E, Strom M, et al. Sinovial fluid cytokines in patients with rheumatoid arthritis or other arthritis lesions. Scancd J Immunol,1998,48: 286-292.
5Maury CPJ. Mechanism of anemia in rheumatoid arthritis: demonstration of raised interleukin 1β concentrations in anemia patients and interleukin-1 madiated suppression of normal erythropoisis and proliferation of human erytholeukaemia (HEL) cell in vitro. Ann Rheum Dis, 1988,47:972-976.
6Gudbjornsson B, Hallgren R, Wide L, et al. Response of anemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis, 1992,51:747-750.
